BRELGOMETON
UNII WM2SW47S8J

Substance Identification & Data

This profile provides standardized clinical and technical data for Brelgometon, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WM2SW47S8J.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3060541-19-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
WM2SW47S8J
CAS Registry Number
3060541-19-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BRELGOMETON
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C21H28F3N3O2
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
DWLDFDZUDSQLPP-INHRHCAVSA-N
Line notation for describing the chemical structure and connectivity of atoms.
INN ID
13922
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
Brelgometon
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
c1c(C(F)(F)F)ccc(c1)CN2CCC(N3C2CN(C[C@@H](C)CC)C(=O)[C@@H]3C)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Brelgometon. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Brelgometon

Common Names & Synonyms

brelgometon [INN]

Systematic Nomenclature

(6S,9aRS)-6-methyl-8-[(2S)-2-methylbutyl]-1-{[4-(trifluoromethyl)phenyl]methyl}tetrahydro-2Hpyrazino[1,2-a]pyrimidine-4,7(3H,6H)-dione
2H-Pyrazino[1,2-a]pyrimidine-4,7(3H,6H)-dione, tetrahydro-6-methyl-8-[(2S)-2-methylbutyl]-1-[[4-(trifluoromethyl)phenyl]methyl]-, (6S)-